Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/01/2003US6541238 Vector containing a DNA sequence; Acetobacter xylinum
04/01/2003US6541235 Which retain enzymatic activity and enhance thermal stability; use in detergents
04/01/2003US6541234 Which retain enzymatic activity and ehnances thermal stability
04/01/2003US6541233 β-glucanase from a bacillus
04/01/2003US6541231 Method for the integration of foreign DNA into eukaryotic genomes
04/01/2003US6541226 Method for specifically cleaving double-stranded DNA and kit for the method
04/01/2003US6541225 Methods and compositions for generating human monoclonal antibodies
04/01/2003US6541224 Protein for use in treatment, diagnosis and prevention of autoimmune disease
04/01/2003US6541223 Propagating permissive eukaryotic cells, transiently stressing to increase production of protein, introducing virus stock, incubating, then harvesting viral agent; vaccines, diagnostic assay
04/01/2003US6541222 Plant promoter isolated from Douglas-fir 2S seed storage protein gene
04/01/2003US6541221 For the identification, isolation, and/or expression of genes undiscoverable by current methods; use to isolate nucleic acids coding for proteins, including transmembrane proteins, and in research of human diseases and development
04/01/2003US6541220 Novel parathyroid hormone (PTH), parathyroid hormone related protein (PTHrP), receptors (PTH1R and PTH3R) isolated from zebrafish; vectors, host cells, recombinant methods for producing; use in identifying receptor agonists, antagonists
04/01/2003US6541219 Therapeutic Gene
04/01/2003US6541218 Isolated nucleic acid encoding title protein; genetic engineering; use in diagnosis and treatment of Type B Niemann-Pick Disease
04/01/2003US6541217 Polypeptide for use in the treatment of cancer and hematopoietic defects
04/01/2003US6541210 Viruses; bacteriophage; Hepatitis B; Hepatitis C; autoimmune disease; use to immunize an organism with a peptide that mimics an antigen or pathogenic organism specific to a disease
04/01/2003US6541209 Bioassay; identification of compounds as agonists; use in treatment of diseases and disorders that are related to 5-HT2A and or 5-HT2C serotonin receptors
04/01/2003US6541207 Methods for generating recombined polynucleotides
04/01/2003US6541204 Method of removing nucleic acid contamination in amplification reactions
04/01/2003US6541202 Telomerase reverse transcriptase (TERT) genes from Candida albicans
04/01/2003US6541199 Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
04/01/2003US6541197 Vehicles for stable transfer of green fluorescent protein gene and methods of use for same
04/01/2003US6541036 Placing tumor cells in culture in vitro or ex vivo supplemented with pro-apoptotic agent, transferring tumor cells into diffusion chamber, inserting chamber into human for therapeutically effective time
04/01/2003US6541012 System for the production of AAV vectors
04/01/2003US6541011 A recombinant multivalent antigenic polypeptide containing a first antigenic determinant of a first polypeptide and atleast a second antigenic determinant from a second polypeptide
04/01/2003US6541010 Alphavirus RNA replicon systems
04/01/2003US6541009 Viral vaccines
04/01/2003US6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof
04/01/2003US6541003 An immunizing formulation comprising a plasmid encoding an attenuated, doxycycline-inducible proviral molecular clone of the human immunodeficiency virus type 1, and a pharmaceutical carrier
04/01/2003US6540995 Administering into the solid tumor of a cancer patient, a capsule encapsulating cytochrome P450 producing cells, and the capsule containing a porous membrane to protect the cells from immune system, allows prodrug to pass into the capsule
04/01/2003US6540992 Elk ligand (Elk-L) where elk is a member of the tyrosine kinase receptor family; protects against excitotoxicity, especially of the hipocammpal neurons
04/01/2003CA2424777A1 Novel protein, process for producing the same and use thereof
04/01/2003CA2290906C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
04/01/2003CA2245108C Tandem fluorescent protein constructs
04/01/2003CA2235951C Novel uses of mammalian ctla-8 and related reagents
04/01/2003CA2102129C Growth hormone antagonists
04/01/2003CA2101070C Antigen-presenting capsid with fusion ms2-coat protein
04/01/2003CA1341426C Process for the manufacture of thrombin inhibitors
03/2003
03/28/2003CA2404723A1 Methods related to the a-c repeat z-sequence upstream from the aldose reductase gene
03/27/2003WO2003029411A2 Novel cyclooxygenase variants and methods of use
03/27/2003WO2003025573A1 Multi-analyte assay device with multi-spot detection zone
03/27/2003WO2003025570A1 Method of examining (-) strand rna virus vector having lowered ability to form grains and method of constructing the same
03/27/2003WO2003025542A2 Immune response associated proteins
03/27/2003WO2003025540A2 Differential tagging of polymers for high resolution linear analysis
03/27/2003WO2003025229A1 A method for identifying effector molecules for gene network integration
03/27/2003WO2003025227A1 Detection of rpob sequences of mycobacterium tuberculosis
03/27/2003WO2003025226A1 Method and apparatus for amplification of nucleic acid sequences by using thermal convection
03/27/2003WO2003025222A1 Brain expressed cap-2 gene and protein associated with bipolar disorder
03/27/2003WO2003025220A2 Fusion proteins useful for detecting analytes
03/27/2003WO2003025216A1 Molecular typing of group b streptococci
03/27/2003WO2003025211A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003WO2003025202A2 Engineered templates and their use in single primer amplification
03/27/2003WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor
03/27/2003WO2003025195A2 Nucleic acid constructs for the delivery of polynucleotides into dna-containing organelles,and uses thereof
03/27/2003WO2003025193A1 Plant enzymes for bioconversion
03/27/2003WO2003025191A2 Pseudotyped retroviral vector system
03/27/2003WO2003025190A1 Tumor-specific promoter and use thereof
03/27/2003WO2003025189A2 A packaging complementation cell-line for sv-40 vectors
03/27/2003WO2003025188A1 Use of a lentiviral vector in the treatment of pain
03/27/2003WO2003025187A2 Improvement of gene expression in vectors
03/27/2003WO2003025186A1 Method of altering plant secondary metabolite biosynthesis in plant cells
03/27/2003WO2003025185A1 A method to modify cell number, architecture and yield of plants by overexpressing the e2f transcription factor
03/27/2003WO2003025184A1 Antibiotic-based gene regulation system
03/27/2003WO2003025183A2 Random integration of a polynucleotide after in vivo linearization
03/27/2003WO2003025182A1 Dna for overexpression of growth hormone and utilization thereof
03/27/2003WO2003025181A2 Dna sequences that encode variable regions of antibodies that bind to the prion protein (prp), and prp-binding polypeptides
03/27/2003WO2003025180A1 Human cervical cancer suppressor gene and protein encoded therein
03/27/2003WO2003025179A1 Novel polypeptide, dna thereof and use of the same
03/27/2003WO2003025178A1 Novel protein and dna thereof
03/27/2003WO2003025177A2 Sequences involved in phenomena of tumour suppression, tumour reversion, adoptosis and/or resistance to viruses and the use thereof as medicaments
03/27/2003WO2003025176A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/27/2003WO2003025175A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/27/2003WO2003025174A2 Regulation of human mrp1-like protein
03/27/2003WO2003025173A1 Novel antisense oligonucleotide derivatives to hepatitis c virus
03/27/2003WO2003025172A2 Gene expression construct
03/27/2003WO2003025171A2 Modulation of retinoic acid receptor gene expression and therapeutic uses thereof
03/27/2003WO2003025170A1 Sample processing device and sample processing method
03/27/2003WO2003025169A2 Nucleic acid for cloning vector
03/27/2003WO2003025165A1 Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes
03/27/2003WO2003025164A2 A gene encoding cyclododecanone monooxygenase
03/27/2003WO2003025163A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
03/27/2003WO2003025161A1 Site-specific recombinase based method for producing adenoviral vectors
03/27/2003WO2003025159A1 Methods for injecting avian eggs
03/27/2003WO2003025154A2 Methods and compositions for the construction and use of fusion libraries
03/27/2003WO2003025153A2 Enhanced proteins and methods for their use
03/27/2003WO2003025151A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
03/27/2003WO2003025150A2 Lipid-associated molecules
03/27/2003WO2003025149A2 Cell populations which co-express cd49c and cd90
03/27/2003WO2003025148A2 Novel nucleic acids and polypeptides
03/27/2003WO2003025146A2 Production of a transgenic avian by cytoplasmic injection
03/27/2003WO2003025145A2 Nanomachine compositions and methods of use
03/27/2003WO2003025144A2 Antisense modulation of ksr expression
03/27/2003WO2003025141A2 Genetic analysis for stratification of cancer risk
03/27/2003WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003WO2003025139A2 Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
03/27/2003WO2003025138A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003WO2003025132A2 Dna polymerases and mutants thereof
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025130A2 Receptors and membrane-associated proteins
03/27/2003WO2003025129A2 Neurotransmission-associated proteins
1 ... 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 ... 4023